Fact-checked by Grok 2 weeks ago

Samprada Singh

Samprada Singh (1925 – 27 July 2019) was an pharmaceutical entrepreneur best known as the founder and longtime chairman of , a multinational company he established in 1973 that grew into one of India's leading pharmaceutical firms with global operations across multiple continents. Born into a middle-class farming family in Okri village, , , Singh was the first person from his village to earn a B.Com. degree from , though financial constraints prevented him from pursuing his initial ambition of becoming a . Singh began his in the pharmaceutical sector in 1953 by opening a small medical store, followed by founding Laxmi Pharma in 1959 as a distribution company and later establishing Magadh Pharma in ; by 1970, he ventured into manufacturing with Aristo Labs before launching , which under his leadership expanded to employ over 21,000 people and improved access to affordable and beyond. As chairman emeritus at the time of his death, Singh and his held a significant stake in Alkem, contributing to his estimated of $3.3 billion as of 2018 and leaving a lasting legacy as an inspirational figure for entrepreneurs from humble beginnings.

Early life

Family background

Samprada Singh was born in 1925 in Okri village, , , . He grew up in a middle-class where formed the backbone of their , with his father working as a . The family's socio-economic status was modest and vulnerable, as their earnings from farming were frequently disrupted by natural calamities such as floods and droughts common in rural . Singh's upbringing in this rural environment exposed him to the rigors of agricultural life from an early age, fostering a strong that later guided his transition to business pursuits.

Education

Samprada Singh, born in the rural village of Okri in , , moved to the urban center of to pursue , marking his first significant exposure to city life and broader opportunities beyond . He completed his matriculation from Ghosi High School in Jehanabad district in 1946 with second division. He then enrolled at Gaya under to study , earning a (B.Com.) honors degree in 1950. This period was challenging due to his humble farming family background, which limited resources, and his initial aspiration to pursue , which he was unable to fulfill due to insufficient marks, leading him to specialize in instead. During his studies, Singh demonstrated dynamism through active participation in various , honing skills that would later prove invaluable. His commerce education provided a foundational understanding of principles, , and , equipping him with the acumen essential for navigating the commercial aspects of the in his subsequent career.

Business career

Early ventures

Samprada Singh's entry into business occurred in 1953 when he opened a small chemist shop in Patna, Bihar, near Patna Medical College and Hospital, initiating his involvement in the pharmaceuticals sector. This modest retail operation served as his foundational venture, allowing him to engage directly with the local healthcare needs in a region still recovering from the economic disruptions of partition and independence. Managing the shop provided Singh with practical insights into pharmaceutical retail, including handling inventory, customer interactions, and negotiations with suppliers amid a market dominated by imported drugs. The post-independence Indian posed significant challenges for such small-scale enterprises, characterized by limited access to capital, inefficiencies, and heavy reliance on foreign pharmaceuticals, as documented by the Pharmaceutical Enquiry Committee in 1953. Additionally, low profit margins in retail chemistry constrained growth, prompting Singh to seek expansion opportunities. By 1959, Singh transitioned from pure retail by establishing Laxmi Pharma, a pharmaceutical distribution company in Patna, which broadened his operations to wholesale supply and deepened his understanding of the industry's logistics. Around 1960, he founded Magadh Pharma, another distribution business in Patna. Over the 1950s and 1960s, these experiences fueled his growing ambitions to move beyond distribution toward manufacturing, driven by the recognition of untapped potential in domestic production to address market constraints and import dependencies. In 1970, he ventured into manufacturing with Aristo Labs.

Founding and growth of Alkem Laboratories

In 1973, Samprada Singh co-founded in with his brother, Basudeo Narayan Singh, leveraging their prior experience in to establish a manufacturing-focused enterprise. The company initially concentrated on the production of generic drugs, aiming to provide affordable, high-quality medications to address gaps in the Indian pharmaceutical market, which was dominated by multinational firms at the time. This entry positioned Alkem as a domestic player emphasizing formulations for acute therapies, such as anti-infectives and analgesics. Key milestones during the and included the establishment of Alkem's first manufacturing facility in Taloja, near , in 1978, where it began producing capsules, tablets, and oral liquids to scale operations. By 1984, the company had reached Rs 10 in revenue, reflecting steady domestic growth. In the 1990s, Alkem diversified its product portfolio into nutraceuticals and a broader range of pharmaceutical formulations, including expansions like a second production plant in Mandva, , in 1992, which supported increased output for the Indian market. Through these developments, Alkem solidified its position as a leading domestic player. Under Samprada Singh's tenure, the company grew substantially, with domestic sales accounting for the majority of its operations by the early .

Leadership and global expansion

Samprada Singh served as the founder and Chairman of from its inception in 1973, guiding the company through strategic decisions that established operations across more than 40 countries, including , , the , , and the . Under his leadership, Alkem prioritized high-quality manufacturing and in international generics, leveraging acquisitions such as the 2010 purchase of Ascend Laboratories, a U.S.-based facility, to bolster its foothold in the American market. Singh implemented robust export strategies focused on trade generics and nutraceuticals, forging partnerships with global distributors to expand Alkem's footprint beyond and address unmet healthcare needs in emerging markets. These efforts included targeted compliance with stringent international regulations, such as obtaining approvals from the U.S. FDA, , and UK MHRA for multiple manufacturing sites, ensuring Alkem's products met global standards for safety and . His oversight extended to in drug formulations, exemplified by the development and launch of key products like the Taxim, which achieved significant sales milestones. In 2017, Singh transitioned from active Chairman to Chairman Emeritus, handing over day-to-day leadership to his grandson while retaining influential advisory oversight until his passing in 2019. This shift allowed him to focus on long-term vision, solidifying Alkem's position as a global pharmaceutical player with 19 manufacturing units and a diverse portfolio serving international markets.

Family and personal life

Immediate family

Samprada Singh was married to Nanhamati Singh, who served as a pillar of support in his family and business endeavors until her passing. He had three sons—Naval Kishore Singh, Satish Kumar Singh, and Balmiki Prasad Singh—who are all promoters of Alkem Laboratories and play significant roles in the family's business dynamics. Naval Kishore Singh served as a director on the company's board until 2015 and remains a key family , while Satish Kumar Singh and Balmiki Prasad Singh have held positions, including Balmiki as former , contributing to the continuity of family leadership. Singh's younger brother, Basudeo Narayan Singh, co-founded with him in 1973 and currently serves as executive chairman, embodying the central role of familial collaboration in the company's governance and strategic direction. As of 2018, the Singh family collectively held a stake approaching 80% in , reflecting their dominant control over the pharmaceutical enterprise.

Philanthropic activities

Samprada Singh's philanthropic endeavors emphasized healthcare and , driven by his deep connection to 's rural communities and his experience in the pharmaceutical sector. He actively supported charitable causes aimed at enhancing access to affordable medical care and educational opportunities for the underprivileged. Under his leadership as founder and chairman of , the company established the Alkem Foundation as its dedicated CSR arm in alignment with India's mandate, channeling resources toward social development in underserved regions. This foundation focused on healthcare initiatives in , including funding for medical programs that addressed prevalent issues like and cancer detection among low-income populations in rural areas. For instance, the Alkem Anemia Mukti Abhiyaan provided nutritional supplements and awareness campaigns to combat in states including , benefiting thousands of women and children. In education, Singh's contributions supported endowments and scholarships targeting students from rural and other underprivileged backgrounds, promoting access to higher learning and skill development. These efforts reflected his belief in empowering through education to break cycles of . The Alkem Foundation's programs, such as library setups in government schools and financial aid for meritorious students, were key examples of this commitment during his tenure. Singh also established community development trusts through the foundation, prioritizing affordable medicines distribution and rural infrastructure improvements in , which extended his business ethos of accessible healthcare into broader social impact. His family's ongoing involvement has sustained these initiatives via the Alkem Foundation. In 2025, the Alkem Foundation supported the establishment of the Samprada Singh Memorial Radiotherapy Centre in , , enhancing cancer care in the region.

Honors and recognition

Major awards

In 2004, Samprada Singh received the Lifetime Contribution Award from the Express Pharma Excellence Awards. In 2009, Samprada Singh received the Lifetime Achievement Award from the Pharmaceutical Leadership Summit & Awards, an event organized in to honor contributions to the Indian healthcare sector under the theme "Destination – Challenges & Opportunities." The award recognized his pivotal role in advancing the through the establishment and growth of , particularly in generics manufacturing, where he demonstrated visionary leadership in making affordable medicines accessible across . Presented during a summit attended by over 300 industry leaders, bureaucrats, and professionals, the accolade highlighted criteria such as long-term impact on industry innovation, operational excellence, and contributions to drug accessibility, with Singh honored alongside other stalwarts for their enduring influence. In 2014, Singh was awarded the Business Leader of the Year at the 7th Annual Pharmaceutical Leadership Summit. In 2017, Singh was jointly awarded the Entrepreneur of the Year in the Life Sciences & Healthcare category, shared with his brother Basudeo Narain Singh, for exemplary entrepreneurial achievements in building Alkem into a leading generics powerhouse. This prestigious recognition, announced at the national awards ceremony, celebrated criteria including sustained business growth, innovative strategies in , and leadership that scaled operations to serve millions through cost-effective generic drugs. The award underscored Singh's contributions to global expansion in generics, emphasizing his role in fostering innovation and efficiency in India's pharma sector amid competitive challenges. In 2017, Singh received the Global Asian of the Year award, presented at the Business & Social Forum 2018.

Wealth rankings

Samprada Singh's financial success was predominantly tied to his controlling interest in , the pharmaceutical company he co-founded. In 2017, estimated his at $3.3 billion, positioning him as the 43rd richest individual in on the publication's annual list of the country's 100 wealthiest people. By 2018, Singh retained his $3.3 billion according to ' India's Richest list, where he ranked 46th nationally and was recognized as the wealthiest person from , a distinction that underscored regional pride in his achievements. His wealth accumulation was driven by the substantial growth in ' valuation, particularly after its in December 2015, which saw the company's rise from approximately ₹165 billion at listing to ₹263.6 billion by the end of 2017. This expansion reflected the firm's increasing market presence in the domestic pharmaceutical sector and bolstered Singh's personal fortune through his family's majority stake.

Death and legacy

Final years

In the 2010s, Samprada Singh transitioned from his active role as chairman to Chairman Emeritus of , where he continued to provide strategic guidance to the company he founded. This shift allowed him to step back from day-to-day operations while remaining influential in shaping the firm's long-term direction. Singh's health began to decline in his later years, leading to an illness that required treatment at Leelavati in . He passed away on 27 July 2019 at the age of 94 in following this illness. In the immediate aftermath of his death, issued a statement confirming the passing of its founder and Chairman Emeritus, noting that Singh "expired today morning." Family members, who control the company, expressed grief over the loss of a visionary leader whose legacy would endure.

Enduring contributions

Samprada Singh's most significant contribution to the lies in his pioneering role in producing affordable medicines, which democratized access to and challenged the long-standing dominance of multinational corporations. By founding in 1973 alongside his brother Basudeo Narayan Singh, he shifted the focus toward cost-effective manufacturing of essential drugs, enabling Indian firms to compete on quality and price against foreign giants that previously controlled over 70% of the market in the . Under Singh's vision, Alkem expanded its global footprint through strategic exports, establishing operations in more than 50 countries across , , the , , and the , thereby positioning as a key player in the international generics . This growth not only generated substantial revenue—reaching billions annually—but also emphasized ethical manufacturing and accessibility, influencing the broader Indian pharma sector to prioritize exports and affordability over branded imports. Singh's journey from a rural middle-class family in Okri village, Jehanabad district, —where he became the first graduate and started with a modest medical store in 1953—serves as a profound inspiration for entrepreneurs from underrepresented regions, particularly in Bihar, by demonstrating the potential for self-made success in a competitive . His achievements elevated the visibility of Bihari business leaders, firing the imagination of a new generation and proving that rural origins need not limit global ambition. Post-2019, has sustained and built upon Singh's foundation under family leadership, with his brother Basudeo N. Singh as executive chairman and relatives like and Dhananjay Kumar Singh in executive roles, driving consistent growth including a of $1.5 billion for the ending March 2025. This continuity reflects Singh's enduring principles of excellence and , as the company now employs over 21,000 people and maintains its commitment to affordable healthcare worldwide. Ultimately, Singh's legacy as a self-made from humble rural roots underscores the transformative power of perseverance in building an enterprise that bridges local needs with global impact, leaving an indelible mark on both the pharmaceutical sector and entrepreneurial aspirations in .

References

  1. [1]
    Founders' Story - Alkem Laboratories
    Mr. Samprada Singh founded Alkem Labs in 1973 and changed the world of Indian pharmaceuticals. Click here to learn more about an inspirational story of two ...
  2. [2]
    Samprada Singh & family - Forbes
    Samprada Singh is the chairman emeritus of Alkem Laboratories, a pharma firm he founded more than 4 decades ago. Singh holds close to 80% with his family ...
  3. [3]
    Alkem Laboratories founder Samprada Singh passes away
    Jul 27, 2019 · Samprada Singh was born in 1925 in Okari village of the Mudanganj block in Jehanabad district of Bihar. Born in a farmer's family, Singh had ...
  4. [4]
    Samprada Singh - Forbes
    Chairman emeritus of Alkem Laboratories, Samprada Singh founded the pharma firm 45 years ago. Farmer's son, Singh worked in a chemist's store before venturing ...
  5. [5]
    Samprada Singh - AsiaOne Magazine
    Jun 18, 2018 · He did his B.Com. honours from Gaya College, Patna University, and demonstrated dynamism through various student activities during the years at ...Missing: challenges | Show results with:challenges
  6. [6]
    Alkemist got winning formula from tiny drops - The Economic Times
    Dec 24, 2005 · How a young Patna University graduate with a simple family background became the head of the major pharmaceutical co in India is Samprada ...Missing: challenges | Show results with:challenges
  7. [7]
    How I Made It - Telegraph India
    Aug 19, 2008 · This is the success story of Samprada Singh, founder and chairman of Alkem Laboratories, a Rs 1,000 crore company. Born and brought up in Bihar ...
  8. [8]
    The right chemistry - India Today
    Nov 27, 2008 · In 1953, he convinced Sitaram Singh, his partner in the umbrella business, to open a medicine shop. He became a retail chemist but the ...Missing: ventures | Show results with:ventures
  9. [9]
    [PDF] Public Policy and Economic Development Case Study of Indian ...
    up since independence was the Pharmaceutical. Enquiry Committee set up by the Ministry of. Commerce in 1953 under the chairmanship of. Major General S. L. ...
  10. [10]
    Alkemist got winning formula from tiny drops
    No readable text found in the HTML.<|control11|><|separator|>
  11. [11]
    Alkem Laboratories founder Samprada Singh passes away
    Jul 29, 2019 · A pharma industry veteran with over 43 years of experience, Singh founded Mumbai-based Alkem Laboratories along with his younger brother Basudeo ...
  12. [12]
    Alkem Laboratories: From pharma distribution to a Rs 11,600 crore ...
    Nov 16, 2023 · August 8, 1973, remains etched in Basudeo Narayan Singh's memory. ... Samprada Singh, his cousin, was the entrepreneurial genius behind Alkem.
  13. [13]
    Alkem Labs Success Story - India's 5th Largest Pharma Company
    Nov 27, 2022 · He established a medical supply store in 1953 ... Thereafter, Samprada Singh founded Magadh Pharma in Patna, his own pharmaceutical distribution ...Missing: early chemist<|control11|><|separator|>
  14. [14]
    [PDF] Alkem Laboratories Ltd. - FundsIndia
    Nov 11, 2016 · Gastro-intestinal (6% market share) and Pain / Analgesics (5% market share). ... Alkem's top therapies Market size in India (FY16). Rs. Cr.<|control11|><|separator|>
  15. [15]
    Alkem Laboratories
    Mr. Singh was born in a middle-class family residing in Okri village of Jehanabad district of Bihar. His family's major earnings came from agriculture, which ...Founders' Story · Alkem Generics · Alkem Foundation · Care at Alkem
  16. [16]
    The Singh Family and Alkem Laboratories - Tikona Capital
    Feb 11, 2025 · "We envisioned a company that wouldn't just manufacture medicines,. " Samprada once declared, "but one that empowered healthcare and improved ...Missing: 1960s | Show results with:1960s
  17. [17]
    The Voice of Sikkim - Facebook
    Aug 27, 2014 · Nanhamati singh wife of Sri.Samprada singh Chairman of Alkem laboratories ltd on her 3rd death anniversary.<|separator|>
  18. [18]
    [PDF] 41> - Alkem Laboratories
    Nawal Kishore Singh, son of Mr. Samprada Singh and brother of Mr. Satish Kumar Singh and Mr. Balmiki Prasad Singh, Promoters of the Company, holding 43 ...
  19. [19]
    Samprada Singh - Wikipedia
    Samprada Singh (1925 – 27 July 2019) was an Indian businessman, who was the founder and chairman of Alkem Laboratories
  20. [20]
    [PDF] ALKEM LABORATORIES LTD.
    Daughter of Naval Kishore Singh. Khushboo Singh. Daughter of Naval Kishore Singh. Anju Singh. Wife of Naval Kishore Singh. Son of Samprada Singh. Son of Basudev ...
  21. [21]
    Balmiki Prasad Singh, Alkem Laboratories Ltd: Profile and Biography
    Balmiki Prasad Singh is Former Executive Director at Alkem Laboratories Ltd. See Balmiki Prasad Singh's compensation, career history, education, ...Missing: roles Naval Kishore Satish Kumar
  22. [22]
    [PDF] ALKEM LABORATORIES LIMITED - SEBI
    Nov 27, 2015 · PROMOTERS OF OUR COMPANY: MR. SAMPRADA SINGH, MR. BASUDEO N. SINGH AND INDIVIDUALS IDENTIFIED AS PROMOTERS AND LISTED IN THE CHAPTER. “OUR ...
  23. [23]
    Samprada Singh: Net Worth & Biography - Goodreturns
    Samprada Singh, born in 1925 and passing on 27 July 2019, was a seminal figure in Indian entrepreneurship as the founder and chairman of Alkem Laboratories.
  24. [24]
    Corporate Social Responsibility - Alkem
    As part of the CSR mandate, we focus on key thematic areas – Healthcare, Education, Rural Development (which includes skill building and promotion of ...Missing: philanthropy | Show results with:philanthropy
  25. [25]
    None
    ### Summary of Alkem Foundation CSR Report 2024-25
  26. [26]
    Pharma Leadership Summit brings together healthcare fraternity
    Apr 9, 2009 · (Lifetime Achievement Award). Samprada Singh, Chairman, Alkem Labs Ltd. (Lifetime Achievement Award); Mr Manohar Kothari, Managing Director, ...
  27. [27]
    Vivek Chaand Sehgal, Nandan Nilekani amongst the winners of EY ...
    Feb 24, 2017 · Life sciences & healthcare award went to Samprada Singh and Basudeo Narain Singh, Chairman Emeritus and Executive Chairman, respectively, of ...
  28. [28]
    Mukesh Ambani Tops the Forbes List of Billionaires in India
    Oct 5, 2017 · Here's the list of Forbes India's 100 Richest 2017: Advertisement ... Samprada Singh, 3.3, Alkem Laboratories, 91. 44, Anil Agarwal, 3.2 ...
  29. [29]
    Alkem Laboratories Market Cap - NSE - Stock Analysis
    Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 677.75B, an increase of 310.26%. That is a compound annual growth rate of ...
  30. [30]
    [PDF] CONSISTENT STRATEGY. STRONG EXECUTION.
    ALKEM LABORATORIES LTD. ANNUAL REPORT 2016-17. Page 2. CONTENTS. Revenue from. Operations. ` 58,525 million. EPS. ` 74.61. 2. 3. 1. Page. Page. Page. 30. 108.Missing: 1980s 1990s
  31. [31]
    [PDF] BUILDING PLATFORMS FOR SUSTAINABLE - Alkem Laboratories
    ... Samprada Singh. Chairman Emeritus. With over four decades of experience and. 750+ brands, we have not only built a strong foothold in the. Indian market but.
  32. [32]
    Alkem group of companies owner Samprada Singh dies
    Jul 27, 2019 · Patna, Jul 27 (UNI) The owner of Alkem group of companies and leading industrialist of Bihar Samprada Singh died following protracted ...
  33. [33]
    https://www.daijiworld.com/news/newsDisplay.aspx?newsID=609379
  34. [34]
    Samprada Singh: The Man who broke Dominance of Foreign Firms ...
    Oct 20, 2024 · Samprada Singh: The Man who broke Dominance of Foreign Firms in Indian Pharma sector. Samprada Singh served as chairman of Alkem Laboratories ...
  35. [35]
    This Bihar Diwas, meet the Bihari outliers who made it big in the ...
    Mar 22, 2022 · Jehanabad native Samprada Singh founded Alkem Laboratories with his brother Basudeo Narayan Singh, in 1973 and served as its chairman till his ...
  36. [36]
    Singh family - Forbes
    The Singh family inherited a majority stake in generics maker Alkem Laboratories, after company founder Samprada Singh passed away in July 2019.Missing: ownership | Show results with:ownership
  37. [37]
    [PDF] for a Healthier Tomorrow - Alkem Laboratories
    Aug 18, 2020 · ... Founder &. Chairman Emeritus. A true visionary and an impactful leader,. Mr. Samprada Singh's story and life are full of wonderful lessons of ...